Clinical Trial

EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC

Name: EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC — clinical trial record (NCT07637448)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is an open-label, multicenter, single-arm clinical study.

Trial Details

NCT Number	NCT07637448
Lead Sponsor	Nanfang Hospital, Southern Medical University
Conditions	Lung Cancer Non-Small Cell Cancer (NSCLC), EGFR Activating Mutation, PD-1 Antibody
Enrollment	32 participants
Start Date	2026-05-21
Primary Completion	2029-03-01 (estimated)
Study Completion	2030-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-09